Related Experiment Videos
Quantitation of phosphorothioate oligonucleotides in human blood plasma using a nanoparticle-based method for
1Research Center for Nucleic Acid and Peptide Chemisty, University of Tübingen, Germany.
Analytical Chemistry
|June 13, 1998
Summary
A new solid-phase extraction method uses cationic polystyrene nanoparticles to efficiently isolate phosphorothioate oligonucleotides from human plasma. This technique achieves high purity and yield for accurate quantification down to 5 nM concentrations.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Nanotechnology
Background:
- Phosphorothioate oligonucleotides are crucial in therapeutics but challenging to isolate from complex biological matrices like human plasma.
- Effective isolation methods are needed for accurate quantification and therapeutic monitoring.
Purpose of the Study:
- To develop a novel, efficient solid-phase extraction (SPE) method for phosphorothioate oligonucleotides from human plasma.
- To optimize SPE conditions for high yield, purity, and direct analysis compatibility.
Main Methods:
- Application of cationic polystyrene nanoparticles for SPE.
- Utilizing pH-controlled adsorption/desorption mechanism based on hydrophobic and electrostatic interactions.
- Analysis of extracted oligonucleotides via capillary gel electrophoresis and electrospray mass spectrometry.
Main Results:
- High binding affinity and isolation of oligonucleotides (≥10 nucleotide units) in high yields and purity.
- Effective extraction at low-nanomolar concentrations (down to 5 nM).
- Low salt contamination enabling direct electrospray mass spectrometry analysis with 60-90% recovery rates.
Conclusions:
- The developed SPE method offers a robust and generally applicable approach for quantitating oligonucleotides in human plasma.
- Optimized carrier systems reduced extraction time to approximately 30 minutes.
- This advancement facilitates therapeutic drug monitoring and pharmacokinetic studies of oligonucleotide-based therapies.